3Mo·
2
2 Commentaires

Classic the shareholder tip
1
@Frei possible. I have them in my portfolio and am considering whether I should buy more here. Or whether I prefer other pharmaceutical stocks because the sector is underrepresented in the portfolio.
Participez à la conversation